Cytokinetics | Umsatzkosten



Cost Of Sales Veränderung Datum
Acadia Pharmaceuticals USD 21.8M 2.95M 2024-12
Amgen USD 3.11B 198M 2024-12
Bayer EUR 5.72B 633M 2024-12
Biogen USD 583.5M 55.2M 2024-12
Bristol-Myers Squibb USD 3.21B 356M 2024-12
Cytokinetics 463K 79.14M 2024-09
Eisai JPY 45.94B 3.42B 2024-12
Eli Lilly USD 2.4B 233M 2024-12
Exelixis USD 19.96M 2.64M 2025-01
Geron 783K 327K 2024-12
Halozyme Therapeutics USD 42.06M 7.37M 2024-12
Intra Cellular Therapies USD 20.4M 5.1M 2024-12
Ionis Pharmaceuticals USD 3.83M 2.76M 2024-12
Ligand Pharmaceuticals USD 2.84M 388K 2024-12
Merck USD 3.71B 181M 2024-12
Novartis USD 3.32B 90M 2024-12
Pfizer USD 5.65B 781M 2024-12
Regeneron Pharmaceuticals USD 565.4M 74.3M 2024-12
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 4.08B 675M 2024-09



Cytokinetics Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.